Effect of Long-term Propranolol Treatment on Hepatocellular Carcinoma Incidence in Patients with HCV-Associated Cirrhosis
Cancer Prevention Research, 08/08/2012
Nkontchou G et al. – This retrospective long–term observational study suggests that propranolol treatment may decrease hepatocellular carcinoma (HCC) occurrence in patients with HCV cirrhosis. These findings need to be verified by prospective clinical trial.